We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 622

2018 Year-End U.S. Legal & Regulatory Developments
  • Paul Weiss
  • USA, United Kingdom, European Union
  • January 14 2019

The following is our summary of significant U.S. legal and regulatory developments during 2018 of interest to Canadian companies and their advisors


HFN Technology & Regulation Client Update
  • Herzog Fox & Neeman
  • USA, Netherlands, United Kingdom, European Union, France
  • December 31 2018

We are pleased to present the latest edition of our monthly Technology & Regulation Client Update, which includes a variety of key regulatory, legal


US health regulator issues new warning for Invokana diabetes drug
  • Leigh Day
  • USA, United Kingdom
  • October 3 2018

Invokana is an oral medication made by Janssen Pharmaceuticals (a division of Johnson & Johnson) prescribed for patients suffering from Type 2


New warnings about silicone breast implants dismissed by the FDA
  • Penningtons Manches LLP
  • USA, United Kingdom
  • September 25 2018

The Food and Drug Administration (FDA) in the US has pushed back on a recent study that suggests that there is an association between silicone breast


Want to have your cake and eat it? Reformulate!
  • Barker Brettell LLP
  • United Kingdom
  • September 20 2018

New regulations, recent government policies and consumer demand are putting pressure on the food and drink manufacturing industry to make healthier


Different types of CAR-T
  • Bristows
  • USA, United Kingdom
  • August 14 2018

CAR-T cell therapy remains an exciting area in healthcare, and a potentially very lucrative one - a recent market study has estimated the value to be


US talc litigation has important lessons for UK insurers
  • RPC
  • USA, United Kingdom
  • August 2 2018

Although it is unlikely litigation involving household staples such as talcum powder could succeed in the UK, the on-going US litigation underlines a


Pharmaceuticals and Brexit: Keeping the industry healthy
  • Linklaters LLP
  • United Kingdom, European Union
  • June 19 2018

It is estimated that each month 37 million packs of medicines are supplied from European countries to the UK with 45 million heading in the other


Life Sciences International Review Q2 2018
  • Morgan Lewis
  • USA, United Kingdom, European Union, France
  • June 6 2018

The most-significant recent development is the entry into force on 25 May of the EU General Data Protection Regulation. This new legislation will have


How do you protect the IP of 3D printed drugs and medical devices?
  • Marks & Clerk
  • USA, United Kingdom
  • February 15 2018

3D printing - also known as additive manufacturing - is set to revolutionise a large number of industries, allowing for innovative product designs and